-
Price Momentum
MEDS is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of MEDS shares has decreased $0.88 since the market last closed. This is a 18.97% drop.
-
Last closed at $3.76.
The stock has since risen $0.20 in pre-market trading.
Key terms
About MEDS
DataMeds AI, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
-
Market cap: $11.93M
A market capitalization up to $300 million places MEDS in the micro-capitalization category.
Key terms
Smart score
Latest MEDS news
MEDS Financials
-
Total revenue: $23.34M (1Y), $1.78M (Q2)
Total Revenue increased 28.73% since last year and increased 14.13% since last quarter.
-
Net income: -$101.27M (1Y), -$18.36M (Q2)
Net Income decreased 1377.12% since last year and decreased 137.17% since last quarter.
-
Earnings per share: -$49.98 (1Y), -$7.13 (Q2)
EPS decreased 657.38% since last year and decreased 119.96% since last quarter.
Key terms
MEDS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MEDS Competitors
-
How competitors are chosen
MEDS's competitors are included in the Distribution Services sector and Medical Distributors group
-
Market cap: $11.93M
A market capitalization up to $300 million places MEDS in the micro-capitalization category.
